Skip to main content
Log in

Risikofaktoren des ischämischen Schlaganfalls

Übersicht über die Evidenz in der Primärprävention

Risk in ischemic stroke—review of evidence in primary prevention

  • Übersicht
  • Published:
Der Nervenarzt Aims and scope Submit manuscript

Zusammenfassung

Risikofaktoren sind Merkmale, die mit einem erhöhten Erkrankungsrisiko assoziiert sind. Risikofaktoren haben sowohl in der Primärprävention des ischämischen Schlaganfalls als auch in der klinischen Praxis und der epidemiologischen Forschung eine große Bedeutung. Die zugrunde liegenden Modelle, Methoden und Studiendesigns sind jedoch oft nicht genügend bekannt. Auf der Basis von Interventionsstudien, Kohortenstudien, Fall-Kontroll-Studien und Metaanalysen geben wir in der vorliegenden Arbeit einen aktuellen Überblick über die Primärprävention der wichtigsten etablierten und potenziell beeinflussbaren Risikofaktoren des ischämischen Schlaganfalls. Jeder Risikofaktor wurde nach einem einheitlichen Schema eingeschätzt und systematisch nach Interventionstyp, Evidenzniveau, Risikoreduktion und Prävalenz ausgewertet.

Summary

Risk factors are traits which can increase disease risk. In the case of ischemic stroke, risk factors have important roles in primary prevention, clinical practice, and epidemiological research. However, the underlying models, methods, and suited study design are often unknown. Based on interventions, cohort studies, case control studies, and meta-analyses, we give an up-to-date overall survey of the most important established and modifiable risk factors in the primary prevention of ischemic stroke. Each risk factor was assessed using a uniform pattern and systematically analyzed according to intervention type, evidence level, risk reduction, and prevalence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. (1994) Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 154: 1449–1457

    Article  PubMed  Google Scholar 

  2. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360: 1903–1913

    Article  PubMed  Google Scholar 

  3. (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA 288: 321–333

    PubMed  Google Scholar 

  4. Abbott RD, Donahue RP, MacMahon SW et al. (1987) Diabetes and the risk of stroke. The Honolulu Heart Program. JAMA 257: 949–952

    Article  CAS  PubMed  Google Scholar 

  5. Benavente O, Moher D, Pham B (1998) Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ 317: 1477–1480

    CAS  PubMed  Google Scholar 

  6. Blauw GJ, Lagaay AM, Smelt AH et al. (1997) Stroke, statins, and cholesterol. A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors. Stroke 28: 946–950

    CAS  PubMed  Google Scholar 

  7. Boushey CJ, Beresford SA, Omenn GS et al. (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274: 1049–1057

    CAS  PubMed  Google Scholar 

  8. Bucher HC, Griffith LE, Guyatt GH (1999) Systematic review on the risk and benefit of different cholesterol-lowering interventions. Arterioscler Thromb Vasc Biol 19: 187–195

    CAS  PubMed  Google Scholar 

  9. Bushnell CD,Goldstein LB (2000) Diagnostic testing for coagulopathies in patients with ischemic stroke. Stroke 31: 3067–3078

    CAS  PubMed  Google Scholar 

  10. Chambers BR, You RX, Donnan GA (2000) Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev CD001923

  11. Cina CS, Clase CM, Haynes BR (1999) Refining the indications for carotid endarterectomy in patients with symptomatic carotid stenosis: A systematic review. J Vasc Surg 30: 606–617

    CAS  PubMed  Google Scholar 

  12. Collins R, Peto R, MacMahon S et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Neurol Clin 335: 827–838

    Article  CAS  Google Scholar 

  13. Corrao G, Bagnardi V, Zambon A et al. (1999) Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction 94: 1551–1573

    Article  CAS  PubMed  Google Scholar 

  14. Corvol JC, Bouzamondo A, Sirol M et al. (2003) Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. Arch Intern Med 163: 669–676

    Article  CAS  PubMed  Google Scholar 

  15. Djousse L, Ellison RC, Beiser A et al. (2002) Alcohol consumption and risk of ischemic stroke: The Framingham Study. Stroke 33: 907–912

    Article  CAS  PubMed  Google Scholar 

  16. Donahue RP, Abbott RD, Reed DM et al. (1986) Alcohol and hemorrhagic stroke. The Honolulu Heart Program. JAMA 255: 2311–2314

    Article  CAS  PubMed  Google Scholar 

  17. Ernst E,Resch KL (1993) Fibrinogen as a cardiovascular risk factor: a meta-analysis and review of the literature. Ann Intern Med 118: 956–963

    CAS  PubMed  Google Scholar 

  18. Gillum LA, Mamidipudi SK, Johnston SC (2000) Ischemic stroke risk with oral contraceptives: A meta-analysis. JAMA 284: 72–78

    Article  CAS  PubMed  Google Scholar 

  19. Hart RG, Benavente O, McBride R et al. (1999) Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med 131: 492–501

    CAS  PubMed  Google Scholar 

  20. Heinzlef O, Cohen A, Amarenco P (1997) An update on aortic causes of ischemic stroke. Curr Opin Neurol 10: 64–72

    CAS  PubMed  Google Scholar 

  21. Iso H, Jacobs DR Jr, Wentworth D et al. (1989) Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial. N Engl J Med 320: 904–910

    CAS  PubMed  Google Scholar 

  22. Kawachi I, Colditz GA, Stampfer MJ et al. (1993) Smoking cessation and decreased risk of stroke in women. JAMA 269: 232–236

    Article  CAS  PubMed  Google Scholar 

  23. Kelly PJ, Rosand J, Kistler JP et al. (2002) Homocysteine, MTHFR 677C-T polymorphism, and risk of ischemic stroke: results of a meta-analysis. Neurology 59: 529–536

    CAS  PubMed  Google Scholar 

  24. Kiely DK, Wolf PA, Cupples LA et al. (1994) Physical activity and stroke risk: the Framingham Study. Am J Epidemiol 140: 608–620

    CAS  PubMed  Google Scholar 

  25. Law MR, Wald NJ, Rudnicka AR (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326: 1423

    Article  CAS  PubMed  Google Scholar 

  26. MacMahon S, Peto R, Cutler J et al. (1990) Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Neurol Clin 335: 765–774

    Article  CAS  Google Scholar 

  27. Mulrow CD, Cornell JA, Herrera CR et al. (1994) Hypertension in the elderly. Implications and generalizability of randomized trials. JAMA 272: 1932–1938

    Article  CAS  PubMed  Google Scholar 

  28. Neal B, MacMahon S, Chapman N (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists‘ Collaboration. Neurol Clin 356: 1955–1964

    CAS  Google Scholar 

  29. Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55: 1172–1179

    CAS  PubMed  Google Scholar 

  30. Pahor M, Psaty BM, Alderman MH et al. (2000) Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Neurol Clin 356: 1949–1954

    Article  CAS  Google Scholar 

  31. Prospective studies collaboration (1995) Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Neurol Clin 346: 1647–1653

    Google Scholar 

  32. Psaty BM, Lumley T, Furberg CD et al. (2003) Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA 289: 2534–2544

    Article  CAS  PubMed  Google Scholar 

  33. Psaty BM, Smith NL, Siscovick DS et al. (1997) Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA 277: 739–745

    Article  CAS  PubMed  Google Scholar 

  34. Reynolds K, Lewis LB, Nolen JD et al. (2003) Alcohol consumption and risk of stroke: a meta-analysis. JAMA 289: 579–588

    Article  PubMed  Google Scholar 

  35. Ross SD, Allen IE, Connelly JE et al. (1999) Clinical outcomes in statin treatment trials: a meta-analysis. Arch Intern Med 159: 1793–1802

    Article  CAS  PubMed  Google Scholar 

  36. Shinton R,Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298: 789–794

    CAS  PubMed  Google Scholar 

  37. Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325: 1202

    PubMed  Google Scholar 

  38. Weih M, Junge-Hulsing J, Mehraein S et al. (2000) Hereditary thrombophilia with ischemic stroke and sinus thrombosis. Diagnosis, therapy and meta-analysis. Nervenarzt 71: 936–945

    Article  CAS  PubMed  Google Scholar 

  39. Whisnant JP (1997) Modeling of risk factors for ischemic stroke; The Willis lecture. Stroke 28: 1839–1843

    Google Scholar 

  40. Wolf PA, D’Agostino RB, Belanger AJ et al. (1991) Probability of stroke: a risk profile from the Framingham Study. Stroke 22: 312–318

    CAS  PubMed  Google Scholar 

  41. Wolf PA, D’Agostino RB, Kannel WB et al. (1988) Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 19: 1025–1029

    Google Scholar 

Download references

Danksagung

Wir danken Prof. Dr. Wernecke, Institut für medizinische Biometrie der Charité, Prof. Dr. Willich, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie der Charité und Priv.-Doz. Dr. Matthias Endres, Neurologie der Charité für die Unterstützung und kritische Diskussion des Manuskriptes.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Weih.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Weih, M., Müller-Nordhorn, J., Amberger, N. et al. Risikofaktoren des ischämischen Schlaganfalls. Nervenarzt 75, 324–335 (2004). https://doi.org/10.1007/s00115-003-1639-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00115-003-1639-6

Schlüsselwörter

Keywords

Navigation